Catalyst Wire Dossier Catalyst Wire Dossier

Polidocanol Endovenous Microfoam (PEM)

polidocanol endovenous microfoam · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Polidocanol Endovenous Microfoam (PEM), covering 2014-03-31 to 2014-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM) [Phase 1]

See pricing